Flixotide Inhaler 250 MCG

Name of the medicinal product

Flixotide Accuhaler 250 micrograms

2. Qualitative and quantitative composition

Flixotide Accuhaler is a moulded plastic device containing a foil strip with 28 or 60 regularly placed blisters each containing a mixture of microfine fluticasone propionate (50 micrograms, 100 micrograms, 250 micrograms or 500 micrograms) and larger particle size lactose.

Excipient with known effect:

Lactose

3. Pharmaceutical form

Multi-dose dry powder inhalation device.

4. Clinical particulars

4.1 Therapeutic indications

Fluticasone propionate given by inhalation offers preventative treatment for asthma. At recommended doses it has a potent glucocorticoid anti-inflammatory action within the lungs, with a lower incidence and severity of adverse effects than those observed when corticosteroids are administered systemically.